Laurent Metz
Director, Health Economics & Reimbursement for Umbrella Markets: EMEA, Asia Pac
6 contactsDirector, Health Economics & Reimbursement for Umbrella Markets: EMEA, Asia Pac, Latin America, Johnson & Johnson Medical
Ø Lead the development and implementation of health economics strategies and tactics for the Umbrella Markets covering Western Europe, Scandinavia, Eastern Europe, Central Europe, Russia and Middle East, Asia Pacific and Latin America.
Ø Prepare reimbursement dossiers in collaboration with regional and local teams.
Ø Design and implement cost-minimization and cost-effectiveness models to support local product adoption.
Ø Implement clinical and economic studies to generate outcome data and support local reimbursement submissions.
Ø Train sales and marketing organizations on selling outcome data to expedite product adoption.
Ø Evaluate the impact of health care reforms on the Franchise business.
Ø Devise tools and processes to perform consistent reimbursement assessment on a worldwide basis.
Ø Active member of the Eucomed Funding and Reimbursement task force.
Senior Health Economics and Reimbursement Director for the United States, GYNECARE WORLDWIDE, a Johnson & Johnson company
Ø Proactively developed and implemented health economics and reimbursement strategies for Gynecare US in the hospital, outpatient and office-based sectors.
Ø Devised specific strategies and tools to expand endometrial ablation treatments in the physician’s office.
Ø Provided early input to clinical protocol in the following disease areas; diagnosis and treatment of stress urinary incontinence, dysfunctional uterine bleeding, adhesions prevention, and hysteroscopic surgery.
Ø Led the implementation of outcome research programs in dysfunctional uterine bleeding treatments.
Ø Built and developed relationships with key gynecologists specialized in coding.
Ø Established strategic partnerships with key customers to develop practice management approaches.
Ø Provided a health economics and reimbursement leadership to the L&A and discovery team for go/no-go decisions in the following areas; diagnosis and treatment of urinary incontinence, uterine bleeding, adhesion prevention, breast and cervix cancer, and tubal sterilization.
Ø Identified the need for the design, development and delivery of training materials to multiple audiences (sales, marketing, senior management and board members).
Ø Coordinated the activities of the field reimbursement group : 3 people
- Developed and communicated tools that reflect the value proposition to payers and economic purchasers
- Analyzed the impact of health care compliance issues on reimbursement for field support